Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 429-790-9 | CAS number: 137281-39-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1 December 1998 to 5 January 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- other: Body responsible for the test
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study was conducted prior to the entry into force of 1907/2006 regulation.
Test material
- Reference substance name:
- 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid
- EC Number:
- 429-790-9
- EC Name:
- 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid
- Cas Number:
- 137281-39-1
- Molecular formula:
- Hill formula: C15 H14 N4 O3 CAS formula: C15 H14 N4 O3
- IUPAC Name:
- 4-(2-{2-amino-4-oxo-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethyl)benzoic acid
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Compound 202723
- Storage condition of test material: In the dark at ambient temperature
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: A reputable UK based supplier
- Age at study initiation: less than 12 months
- Weight at study initiation: 295-358 grams
- Housing: aluminimum cages
- Diet: ad libitum supply of 'Guinea Pig Diet FD1' animal feed
- Water: ad libitum supply of domestic mains water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 19 -20 °C
- Humidity: 35%
- Air changes (per hr): 15
- Photoperiod: 12 hour light/dark cycle (light hours 07:00-19:00)
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- water
- Remarks:
- distilled
- Concentration / amount:
- INDUCTION - Intradermal injections: 2% compound 202723 in vehicle (1:1) so final concentration in vehicle reported is 1%
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- water
- Remarks:
- Distilled
- Concentration / amount:
- INDUCTION - Epicutaneous application: 50% compound 202723 in distilled water
Challenge
- No.:
- #1
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- water
- Remarks:
- distilled
- Concentration / amount:
- Epicutaneous application: 50% compound 202723 in distilled water
- No. of animals per dose:
- Number of animals in test group: 10
Number of animals in control group: 5 - Details on study design:
- RANGE FINDING TESTS:
See Table 1 below for more information on the dose levels of compound 202723 included in the range finding study. Dose levels selected for induction phase were the highest that caused mild to moderate skin irritation and were also well tolerated systemically. Whilst dose levels selected for the challenge phase were the highest concentrations that did not cause irritation.
MAIN STUDY INDUCTION - Intradermal Injections
On Day 0 each animal was treated with 6 intradermal injections (see Table 2 for more information). Test site observations followed 24 hours after injection of test material.
MAIN STUDY INDUCTION - Epicutaneous Application
Six days after administration of the intradermal injections, 0.5ml of 10% sodium lauryl sulphate was applied to the treatment area of each animal (including control group). On the following day each animal was treated with one epicutaneous application to the scapular region under a Webril patch (s ee Table 3 for more information). The patches were removed after 48 hours and then the test sites w ere wiped with distilled water.
Test site observations followed 24 hours after removal of the patches.
MAIN STUDY CHALLENGE - Epicutaneous Application
Thirteen days after topical application. On the following day each animal was treated with test mate rial and vehicle topically on both flanks of the main study animals under 2 Webril patches (see Table
4 for more information). Patches were removed after 24 hours of exposure to the test material. Test site observations followed at 24 hours and 48 hours after removal of the patches.
SCORING SYSTEM
Scoring system used to assess any clinical observations recorded was as follows:
- No visible change Grade 0
- Discrete or patchy erythema Grade 1
- Moderate or confluent erythema Grade 3
- Intense erythema and swelling Grade 4 - Challenge controls:
- See "details on study design"
- Positive control substance(s):
- yes
- Remarks:
- 2-mercaptobenzothiazole
Results and discussion
- Positive control results:
- A positive control was completed on 5 January 1999. Following challenge with mercaptobenzothiazole at a dose level of 25% w/v in maize oil, 100% of the test group animals and none of the control group animals reacted positively. These results demonstrate the ability of the test method to identify a mild/ moderate sensitiser.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
Any other information on results incl. tables
Maximum concentration not causing irritating effects in preliminary test 50%
Signs of irritation during induction - intradermal injection: discrete erythema noted in every animal.
Topical application: no erythemia reactions noted in any animal
Evidence of sensitisation of each challenge concentration: None
Other observations: None.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Substance not classified as skin sensitiser.
- Executive summary:
The delayed contact hypersenstivity of compound 202723 was investigated by means of a Magnusson- Kligman Maximisation Test in guinea pigs.
The Magnusson-Kligman Maximisation test comprises of 2 procedures: an induction and a challenge procedure.The induction procedure consisted of exposure to the test material via 2 routes,intradermal injection and topical application. The animals were also exposed to an adjuvant material via intradermal injection. This was followed by a challenge exposure to the test material via topical application.
Two groups of animals were used in the study, a test and a control group.The test group contained 10 animals and the Control Group contained 5.During the induction procedure, the test group was exposed to 1% compound 202723 via intra dermal injection and 50% compound 202723 via topical application. The control group was exposed to vehicle, distilled water, only during this procedure.
Following challenge with 50% compound 202723, no positive response was noted in any of the test or control group animals. Under the conditions of the study, compound 202723 is considered not to be a sensitiser in guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.